摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-(acetylamino)ethyl]acrylamide

中文名称
——
中文别名
——
英文名称
N-[2-(acetylamino)ethyl]acrylamide
英文别名
N-(2-acetamidoethyl)prop-2-enamide
N-[2-(acetylamino)ethyl]acrylamide化学式
CAS
——
化学式
C7H12N2O2
mdl
——
分子量
156.184
InChiKey
TXUXGAPNYCRQJK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    58.2
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-乙酰-L-半胱氨酸N-[2-(acetylamino)ethyl]acrylamideammonium hydroxide 作用下, 以 为溶剂, 以28%的产率得到
    参考文献:
    名称:
    硫醇基迈克尔型加成。系统评估其控制因素
    摘要:
    本文是关于控制这种流行的生物共轭反应动力学和产物稳定性的因素。我们证明a)硫醇pKa,即硫醇盐的量,是亲核试剂反应动力学的唯一决定因素;b)产物降解主要通过水解(而非硫醇交换)发生,并且对于反应最迅速的亲电试剂更为突出。在分子设计方面,丙烯酰胺和低pKa硫醇作为反应伙伴出现,为稳定性和反应速率提供了最佳折衷方案。
    DOI:
    10.1016/j.tet.2020.131637
  • 作为产物:
    描述:
    N-乙酰基乙二胺丙烯酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 以53%的产率得到N-[2-(acetylamino)ethyl]acrylamide
    参考文献:
    名称:
    硫醇基迈克尔型加成。系统评估其控制因素
    摘要:
    本文是关于控制这种流行的生物共轭反应动力学和产物稳定性的因素。我们证明a)硫醇pKa,即硫醇盐的量,是亲核试剂反应动力学的唯一决定因素;b)产物降解主要通过水解(而非硫醇交换)发生,并且对于反应最迅速的亲电试剂更为突出。在分子设计方面,丙烯酰胺和低pKa硫醇作为反应伙伴出现,为稳定性和反应速率提供了最佳折衷方案。
    DOI:
    10.1016/j.tet.2020.131637
点击查看最新优质反应信息

文献信息

  • STIMULI RESPONSIVE COMPOSITIONS FOR IRON CHELATION
    申请人:Xiong May Pang
    公开号:US20160184344A1
    公开(公告)日:2016-06-30
    The present technology provides new compositions comprising at least one cross-linked co-polymer. In some embodiments, the polyacrylamide co-polymer comprises water soluble subunits, cross-linking subunits, and iron chelating subunits. In other embodiments, the co-polymer comprises water soluble units, cross-linking subunits, and substituted subunits, which can be conjugated with iron-chelating agents. When these new particles are exposed to certain environments, such the presence of strong acids or oxidation agents, these particles are capable of breaking up so that the iron chelating agents can chelate iron or other metals from their environments. Methods to prepare these new compositions are also provided. These compositions or compositions comprising nanogels of the present technology may be used to treat metal overload conditions such as iron overload resulting from chronic transfusions.
    目前的技术提供了包含至少一种交联共聚物的新组合物。在某些实施例中,聚丙烯酰胺共聚物包括水溶性亚基、交联亚基和铁螯合亚基。在其他实施例中,共聚物包括水溶性单元、交联亚基和取代亚基,这些亚基可以与螯合铁的试剂结合。当这些新颗粒暴露在某些环境中,如强酸或氧化剂的存在时,这些颗粒能够分解,以便铁螯合试剂可以从它们的环境中螯合铁或其他金属。还提供了制备这些新组合物的方法。这些组合物或包含本技术的纳米凝胶的组合物可用于治疗金属过载症状,例如由于慢性输血导致的铁过载。
  • Ion binding polymers and uses thereof
    申请人:Vifor (International) Ltd.
    公开号:US10485821B2
    公开(公告)日:2019-11-26
    The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.
    本发明提供了治疗离子失衡的方法和组合物。特别是,本发明提供了包含钾结合聚合物的组合物及其药物组合物。本文公开了聚合物和药物组合物用于治疗和/或预防的方法。这些方法的例子包括治疗高钾血症,如肾功能衰竭引起的高钾血症和/或使用引起高钾血症的药物。
  • POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE
    申请人:Sakamoto Kei
    公开号:US20100258764A1
    公开(公告)日:2010-10-14
    A polymerizable liquid crystal compound shown by the following formula (I), a polymerizable liquid crystal composition that includes the polymerizable liquid crystal compound and a chiral compound polymerizable with the polymerizable liquid crystal compound, a liquid crystalline polymer obtained by polymerizing the polymerizable liquid crystal compound or the polymerizable liquid crystal composition, and an optical anisotropic article that includes the liquid crystalline polymer. The polymerizable liquid crystal compound shows a liquid crystal phase over a wider temperature range, is chemically stable, can be inexpensively produced, and has a wide selective reflection wavelength band Δλ (i.e., a large value Δn). The polymerizable liquid crystal composition includes the polymerizable liquid crystal compound, the liquid crystalline polymer is obtained by polymerizing the polymerizable liquid crystal compound or the polymerizable liquid crystal composition, and the optical anisotropic article includes the liquid crystalline polymer. wherein Y 1 to Y 6 represent —O—, —O—C(═O)—, —C(═O)—O—, or the like, G 1 and G 2 represent divalent aliphatic groups having 1 to 20 carbon atoms, Z 1 and Z 2 represent an alkenyl group having 2 to 10 carbon atoms or the like, A 1 and A 2 represent divalent organic groups A having 1 to 30 carbon atoms, X 1 to X 8 represent a hydrogen atom or the like, and a and b represent 0 or 1.
  • POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS, LIQUID CRYSTALLINE POLYMERS AND OPTICALLY ANISOTROPIC MATERIALS
    申请人:Sakamoto Kei
    公开号:US20110140041A1
    公开(公告)日:2011-06-16
    A polymerizable liquid crystal compound shown by the following formula, a polymerizable liquid crystal composition that includes the polymerizable liquid crystal compound and a chiral compound polymerizable with the polymerizable liquid crystal compound, a liquid crystalline polymer obtained by polymerizing the polymerizable liquid crystal compound or the polymerizable liquid crystal composition, and an optically anisotropic article that includes the liquid crystalline polymer, are disclosed. wherein Y 1 to Y 6 represent —O—C(═O)— or the like, G 1 and G 2 represent a divalent aliphatic group having 1 to 20 carbon atoms or the like, Z 1 and Z 2 represent an alkenyl group having 2 to 10 carbon atoms or the like, A 1 and A 2 represent a divalent organic group having 1 to 30 carbon atoms, M 1 and M 2 represent a substituted or unsubstituted 2,6-naphthylene group or a substituted or unsubstituted 1,4-phenylene group, provided that at least one of M 1 and M 2 represents a substituted or unsubstituted 2,6-naphthylene group, L 1 and L 2 represent a hydrogen atom or the like, and a and b are 0 or 1. A polymerizable liquid crystal compound that shows a liquid crystal phase over a wide temperature range, is chemically stable, can be produced inexpensively, and has a wide selective reflection wavelength band Δλ (i.e., a large value Δn); a polymerizable liquid crystal composition that includes the compound; a liquid crystalline polymer; and a optically anisotropic article that includes the liquid crystalline polymer as a constituting material; can be provided.
  • POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER AND FILM
    申请人:KATOH SHUNYA
    公开号:US20110237768A1
    公开(公告)日:2011-09-29
    A polymerizable liquid crystal compound represented by formula (I) is disclosed. R 0 and R 1 represent a hydrogen atom, or a C 1-4 alkyl group, provided that at least one of R 0 and R 1 represent a C 1-4 alkyl group; A 0 , A1, B 0 and B 1 represent a single bond, or a divalent linking group having a cyclic structure; X 0 , X 1 , Y 0 and Y 1 represent a single bond, —O—, —S—, —OCO—, —COO—, —OCOO—, —NR 2 CO—, —CONR 2 —, —OCONR 2 —, —NR 2 COO—, —NR 2 CONR 2 —, —C═N— or —N═C—; Q 0 and Q 1 a single bond or a divalent aliphatic group; Z 0 and Z 1 represent a hydrogen atom, cyano, halogen atom or polymerizable group; and n and m each independently represent an integer of from 0 to 2.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物